InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the complete record of transactions filed by Thibaut du Fayet, Chief Executive Officer. Insider active across 1 company, notably Phaxiam Therapeutics. Aggregated, 1 reports have been logged. Activity tracked since 23 June 2023. The latest transaction was filed on 23 June 2023 (Souscription). Regulator: AMF. All data is accessible without signup.
Declarations1 total
54,862 shares@ €0.61100.0% of flowActionHors plateforme de négociation2023DD917744
1 of 1 declaration
About Thibaut du Fayet
Thibaut du Fayet is the Chief Executive Officer of Phaxiam Therapeutics, a company specializing in the development of innovative treatments. He is responsible for the strategic and operational direction of the company, aiming to improve patient health through advanced therapeutic solutions. His leadership is essential for the growth and success of Phaxiam.
